These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30458232)

  • 61. alpha-Tocopheryl succinate sensitizes established tumors to vaccination with nonmatured dendritic cells.
    Ramanathapuram LV; Kobie JJ; Bearss D; Payne CM; Trevor KT; Akporiaye ET
    Cancer Immunol Immunother; 2004 Jul; 53(7):580-8. PubMed ID: 14991239
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Countering the advert effects of lung cancer on the anticancer potential of dendritic cell populations reinstates sensitivity to anti-PD-1 therapy.
    Brassard J; Gill ME; Bernatchez E; Desjardins V; Roy J; Joubert P; Marsolais D; Blanchet MR
    PLoS One; 2021; 16(11):e0260636. PubMed ID: 34847189
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4+CD25+ regulatory T cells.
    Prasad SJ; Farrand KJ; Matthews SA; Chang JH; McHugh RS; Ronchese F
    J Immunol; 2005 Jan; 174(1):90-8. PubMed ID: 15611231
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A combination hybrid-based vaccination/adoptive cellular therapy to prevent tumor growth by involvement of T cells.
    Savai R; Schermuly RT; Pullamsetti SS; Schneider M; Greschus S; Ghofrani HA; Traupe H; Grimminger F; Banat GA
    Cancer Res; 2007 Jun; 67(11):5443-53. PubMed ID: 17545626
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
    Gonzalez-Carmona MA; Lukacs-Kornek V; Timmerman A; Shabani S; Kornek M; Vogt A; Yildiz Y; Sievers E; Schmidt-Wolf IG; Caselmann WH; Sauerbruch T; Schmitz V
    Hepatology; 2008 Jul; 48(1):157-68. PubMed ID: 18537185
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Therapeutic effect of MIP-1alpha-recruited dendritic cells on preestablished solid and metastatic tumors.
    Cao Q; Jin Y; Jin M; He S; Gu Q; He S; Qiu Y; Ge H; Yoneyama H; Zhang Y
    Cancer Lett; 2010 Sep; 295(1):17-26. PubMed ID: 20202744
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MCA106 fibrosarcoma cells transduced with granulocyte/macrophage colony-stimulating factor are not superior to the wild-type cells in suppressing the growth of hepatic metastases.
    Dong XD; Abdel-Wahab Z; Dematos P; Fong T; Pruitt SK; Seigler HF
    J Surg Oncol; 1999 May; 71(1):36-45. PubMed ID: 10362090
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Feasibility of using hepatitis B virus surface antigen as target antigen in immunogen therapy against cancer].
    Qiu S; Ye S; Tang Z; Qian S; Li L
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):253-6. PubMed ID: 11953174
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.
    Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL
    Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy.
    Teitz-Tennenbaum S; Li Q; Okuyama R; Davis MA; Sun R; Whitfield J; Knibbs RN; Stoolman LM; Chang AE
    J Immunother; 2008 May; 31(4):345-58. PubMed ID: 18391761
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Anti-melanoma vaccinal capacity of CD11c-positive and -negative cell populations present in GM-CSF cultures derived from murine bone marrow precursors.
    Campisano S; Mac Keon S; Gazzaniga S; Ruiz MS; Traian MD; Mordoh J; Wainstok R
    Vaccine; 2013 Jan; 31(2):354-61. PubMed ID: 23146677
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Enhanced dendritic cell-based immunotherapy using low-dose cyclophosphamide and CD25-targeted antibody for transplanted Lewis lung carcinoma cells.
    Son CH; Bae JH; Lee HR; Shin DY; Yang K; Park YS
    J Immunother; 2015 Apr; 38(3):107-15. PubMed ID: 25751500
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma.
    Pajtasz-Piasecka E; Rossowska J; Duś D; Weber-Dabrowska B; Zabłocka A; Górski A
    Immunol Lett; 2008 Feb; 116(1):24-32. PubMed ID: 18166233
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Enhanced antitumor effects induced by lymphotactin gene-modified dendritic cells after pulsed with tumor antigen peptide].
    Zhang W; He L; Cao X
    Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):170-3. PubMed ID: 11601032
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [GM-CSF gene-modified dendritic cell vaccine enhances antitumor immunity in vitro].
    He SB; Sun K; Wang L; Li DC; Zhang YY
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):410-4. PubMed ID: 20819479
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Generation of anti-tumor response by JAWS II mouse dendritic cells transduced with murine interleukin 12 genes.
    Pajtasz-Piasecka E; Rossowska J; Szyda A; Krawczenko A; Dus D
    Oncol Rep; 2007 May; 17(5):1249-57. PubMed ID: 17390073
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Immunotherapeutic effects of beta-elemene combined with interleukin-23 gene-modified dendritic cells on murine pancreatic carcinoma].
    Tan G; Wang ZY; Wang XG; Cheng L; Yin S
    Ai Zheng; 2006 Sep; 25(9):1082-6. PubMed ID: 16965646
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Depletion of regulatory T cells by anti-ICOS antibody enhances anti-tumor immunity of tumor cell vaccine in prostate cancer.
    Mo L; Chen Q; Zhang X; Shi X; Wei L; Zheng D; Li H; Gao J; Li J; Hu Z
    Vaccine; 2017 Oct; 35(43):5932-5938. PubMed ID: 28923424
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING.
    Wang L; Luo R; Onyshchenko K; Rao X; Wang M; Menz B; Gaedicke S; Grosu AL; Firat E; Niedermann G
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37640480
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    Cai Z; Liu R; Chan C; Lu Y; Winnik MA; Cescon DW; Reilly RM
    Mol Pharm; 2022 Nov; 19(11):4199-4211. PubMed ID: 36287201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.